BlackRock Investment Management, LLC - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 112 filers reported holding PARATEK PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 3.09 and the average weighting 0.6%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$1,130,000
+16.4%
73,378
-1.7%
0.00%0.0%
Q3 2016$971,000
+29.0%
74,653
+37.9%
0.00%0.0%
Q2 2016$753,000
+15.5%
54,133
+25.9%
0.00%0.0%
Q1 2016$652,000
-17.8%
42,998
+2.9%
0.00%0.0%
Q4 2015$793,000
+0.4%
41,787
+0.5%
0.00%0.0%
Q3 2015$790,000
-27.7%
41,564
-1.9%
0.00%0.0%
Q2 2015$1,092,000
+15500.0%
42,385
+19522.7%
0.00%
Q1 2015$7,000
-12.5%
2160.0%0.00%
Q4 2014$8,0002160.00%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Omega Fund Management, LLC 2,600,410$16,279,0002.44%
Abingworth LLP 1,041,131$6,517,0002.23%
Telemetry Investments, L.L.C. 194,789$1,219,0002.06%
AIGH Capital Management LLC 749,608$4,692,0001.91%
Trellus Management Company, LLC 340,000$2,128,0001.76%
Bruce & Co., Inc. 929,312$5,817,0001.12%
Worth Venture Partners, LLC 191,093$1,196,0000.95%
GENERAL AMERICAN INVESTORS CO INC 1,000,751$6,265,0000.62%
Weil Company, Inc. 104,907$657,0000.39%
NEXPOINT ASSET MANAGEMENT, L.P. 140,020$877,0000.29%
View complete list of PARATEK PHARMACEUTICALS INC shareholders